Medtronic Cardiac Surgery PMCF Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMedtronic Cardiac Surgery

About this trial

This registry is being conducted to support ongoing post-market surveillance activities.

Eligibility criteria

Qualifiers

Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements

Patient has or is intended to receive or be treated with an eligible product

Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment

Disqualifiers

Patient who is, or is expected to be, inaccessible for follow-up

Patient prohibited from participation by local law

Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results

Trial design

Treatments tested in this trial

  • Surgical Heart Valve Repair Products
  • Surgical Heart Valve Replacement Products

Treatment groups

2,700 Participants
are divided into 1 treatment group

Locations

26
Austria
Allgemeines Krankenhaus - Universitätskliniken Wien1090, Vienna Austria
Belgium
UZ Leuven3000, Leuven Belgium
France
Hôpital Haut-Lévêque - CHU de Bordeaux33604, Pessac France
Germany
Schüchtermann-Klinik49214, Bad Rothenfelde Germany

Sponsors and collaborators

Medtronic Cardiac Surgery

Lead sponsor